Senior Applied AI/ML Engineer
TetraScience- Full Time
- Senior (5 to 8 years)
Employment Type: [Not Specified] Location Type: [Not Specified] Salary: [Not Specified]
Xaira is an innovative biotech startup focused on leveraging AI to transform drug discovery and development. The company is leading the development of generative AI models to design protein and antibody therapeutics, enabling the creation of medicines against historically hard-to-drug molecular targets. It is also developing foundation models for biology and disease to enable better target elucidation and patient stratification. Collectively, these technologies aim to continually enable the identification of novel therapies and to improve success in drug development. Xaira is headquartered in the San Francisco Bay Area, Seattle, and London.
We are seeking an experienced AI Research Engineer to join our team and lead some of our efforts in building the AI powered future of drug discovery. As a senior member of our interdisciplinary group, you will collaborate closely with AI scientists, other engineers, and drug discovery experts to help develop AI models to accelerate the identification and development of novel therapeutics. This role offers a unique opportunity to leverage cutting-edge AI techniques to address pressing challenges in healthcare and contribute to improving human health globally.
If you are a motivated individual with a passion for applying AI to advance drug discovery, we encourage you to apply.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.